Back to search results

Observational Study of NMP® for Cervical Spine Fusion

This study is looking at the safety of a human bone allograft called Natural Matrix Protein (NMP®) Fibers when used in cervical spine fusion surgery. This surgery involves removing a damaged disc in your neck (between C2 and T1 vertebrae) and replacing it with a bone void filler to help the bones fuse together. Researchers are reviewing existing patient records to see how often patients experience side effects or need another surgery after receiving NMP® Fibers. To join this study, you must be at least 18 years old and have already had cervical spine fusion with NMP® Fibers at the study site between 2022 and 2025, with at least 90 days of follow-up data available. The study will measure safety by tracking adverse events (side effects) and re-operation rates for up to two years after surgery. The current status of this study is unclear.

Study design
This is an observational study reviewing existing patient records. It aims to enroll 300 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants' records will be reviewed for adverse events and re-operation rates from 90 days up to 24 months after their surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07245940

Assessing Safety of Cervical Spine Fusion With NMP®

Not Yet Recruiting
Not specifiedAges 18+Observational
Red Rock Regeneration Inc.
~300 participants
Updated 2025-11-24 on ClinicalTrials.gov
What's tested:Natural Matrix Protein (NMP) FibersCervical interbody fusion

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Adverse Event Reporting
Measured over 90 days - 24 months postoperatively
+1 more outcome measured

Conditions

Degenerative Disc Disease
Degenerative Spondylolisthesis
Spinal Stenosis Cervical

Explore related trials

Degenerative spondylolisthesisIntervertebral Disc Degenerative DisorderSpinal Stenosis

Where it's being run

1 sites across 1 states
Alabama1

Who to contact

Sean A Peel, PhD
[email protected]
416-898-9724
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Exclusion

Patients with no follow-up data within 3 months from the surgery date due to missed postoperative appointments.

What this trial measures

  • Adverse Event Reporting90 days - 24 months postoperatively

    assessment of the incidence and nature of AEs. Complications determined to be related to NMP® within at least 3 months post-op will be collected and reported as part of the primary outcome of this study.

  • Re-operation Rates90 days - 24 months postoperatively

    Re-operation rates determined to be related to NMP® within at least 3 months post-op will be collected and reported as part of the primary outcome of this study.